Kent Van Kampen's Colleagues at Altimmune
Stacey Jurchison
Senior Director, Investor Relations and Corporate Communications
Kent Van Kampen's Contact Details
240-654-1450
Birmingham, Alabama Area
Altimmune
Kent Van Kampen's Company Details
Altimmune is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of infectious disease. NasoVAX our influenza vaccine candidate has unique characteristics, stimulating multiple arms of the immune system that offer the potential to stop infection and the spread of flu, while being easier to administer through an intranasal spray. NasoShield and SparVax-L are two next-generation anthrax vaccine candidates that are intended to improve protection and safety while having favorable dosage and storage requirements compared to other anthrax vaccines.